ArticleJACS Au2025
Site-Selective Benzylic Dehydrogenation of Alkylindoles.
Article in JACS Au, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Benzylic dehydrogenation of alkylarenes represents a crucial transformation in organic synthesis. Notwithstanding the advances reported in this field, achieving precise, tunable site selectivity in the dehydrogenation of molecules with multiple competitive benzylic sites remains an unsolved challenge. Furthermore, achieving this reactivity for dialkylindoles remains elusive. Herein, we report sequential benzylic amination-elimination strategies that allow for the tunably selective benzylic dehydrogenations of alkylindoles at the C2 or C3 position. By employing a commercially available reagent, 4-phenyl-1,2,4-triazoline-3,5-dione (PTAD) or 2,3-dichloro-5,6-dicyano-p-benzoquinone (DDQ)/pyrazole, 2,3-dialkylindoles can be converted into 2-vinyl-3-alkylindoles or 3-vinyl-2-alkylindoles, respectively, with exceptional site control. Mechanistic studies reveal that C2-benzylic dehydrogenation proceeds via a rare aromatization-driven 1,3-urazole migration, generating a C2-aminated intermediate. Through these strategies, regiodivergent access to different vinylindoles from the same substrates can be facilitated. These protocols are characterized by simple operation, a broad substrate scope, and scalability. Their utility is demonstrated through versatile downstream derivatizations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.